Dr. John Day, MD, PhD
Claim this profileStanford University
Studies Atrophy
Studies Muscular Atrophy
11 reported clinical trials
10 drugs studied
Area of expertise
1Atrophy
SMN2 positive
5q SMA positive
SMN1 positive
2Muscular Atrophy
SMN2 positive
5q SMA positive
SMN1 positive
Affiliated Hospitals
Clinical Trials John Day, MD, PhD is currently running
Gene Therapy (AT845)
for Pompe Disease
This is a phase 1/2 open-label, ascending dose, multicenter clinical study to evaluate the safety and efficacy of AT845 in adult (aged ≥ 18 years) subjects, ambulatory or nonambulatory, with Late Onset Pompe Disease (LOPD).
Recruiting1 award Phase 1 & 28 criteria
High-Dose Nusinersen
for Spinal Muscular Atrophy
The primary objective of this study is to evaluate motor function following treatment with HD nusinersen in participants with spinal muscular atrophy (SMA) previously treated with risdiplam. The secondary objective of this study is to evaluate the safety and tolerability of HD nusinersen in participants with SMA previously treated with risdiplam.
Recruiting2 awards Phase 3
More about John Day, MD, PhD
Clinical Trial Related3 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments John Day, MD, PhD has experience with
- Nusinersen
- AT845
- Observational Study
- None
- Motor Outcomes To Validate Evaluations In FSHD (MOVE FSHD)
- BIIB105
Breakdown of trials John Day, MD, PhD has run
Atrophy
Muscular Atrophy
Tooth Decay
Charcot-Marie-Tooth Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does John Day, MD, PhD specialize in?
John Day, MD, PhD focuses on Atrophy and Muscular Atrophy. In particular, much of their work with Atrophy has involved SMN2 positive patients, or patients who are 5q SMA positive.
Is John Day, MD, PhD currently recruiting for clinical trials?
Yes, John Day, MD, PhD is currently recruiting for 2 clinical trials in Palo Alto California. If you're interested in participating, you should apply.
Are there any treatments that John Day, MD, PhD has studied deeply?
Yes, John Day, MD, PhD has studied treatments such as Nusinersen, AT845, Observational Study.
What is the best way to schedule an appointment with John Day, MD, PhD?
Apply for one of the trials that John Day, MD, PhD is conducting.
What is the office address of John Day, MD, PhD?
The office of John Day, MD, PhD is located at: Stanford University, Palo Alto, California 94304 United States. This is the address for their practice at the Stanford University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.